Cited by 1,209Cancer Immunotherapy and BiomarkersSingle-cell and spatial transcriptomicsImmune cells in cancer

Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses

Open access
Lavin, Yonit, Kobayashi, Soma, Leader, Andrew, Amir, El-ad David, Elefant, Naama, Bigenwald, Camille, Remark, Romain, Sweeney, Robert +21 more·2017·Cell

Abstract

To guide the design of immunotherapy strategies for patients with early stage lung tumors, we developed a multiscale immune profiling strategy to map the immune landscape of early lung adenocarcinoma lesions to search for tumor-driven immune changes. Utilizing a barcoding method that allows a simultaneous single-cell analysis of the tumor, non-involved lung, and blood cells, we provide a detailed immune cell atlas of early lung tumors. We show that stage I lung adenocarcinoma lesions already harbor significantly altered T cell and NK cell compartments. Moreover, we identified changes in tumor-infiltrating myeloid cell (TIM) subsets that likely compromise anti-tumor T cell immunity. Paired single-cell analyses thus offer valuable knowledge of tumor-driven immune changes, providing a powerful tool for the rational design of immune therapies. VIDEO ABSTRACT.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2017.04.014

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. Besse B Johnson M Janne PA Janne PA Garassino MC Eberhardt WE Peters S Toh CK Kurata T Li Z 2015 16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD-L1-selected non-small cell lung cancer (NSCLC) European Journal of Cancer 51
  2. Black WC Keeler EB Soneji SS 2015 Cost-effectiveness of CT screening in the National Lung Screening Trial N Engl J Med 372 388 25607437
  3. Blondel VD Guillaume J-L Lambiotte R Lefebvre E 2008 Fast unfolding of communities in large networks Journal of statistical mechanics: theory and experiment 2008 P10008
  4. Broz ML Binnewies M Boldajipour B Nelson AE Pollack JL Erle DJ Barczak A Rosenblum MD Daud A Barber DL 2014 Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity Cancer cell 26 638 652 25446897 PMC4254577
  5. Carlson CS Emerson RO Sherwood AM Desmarais C Chung M-W Parsons JM Steen MS LaMadrid-Herrmannsfeldt MA Williamson DW Livingston RJ 2013 Using synthetic templates to design an unbiased multiplex PCR assay Nature Communications 4 2680 24157944
  6. Chang Q Bournazou E Sansone P Berishaj M Gao SP Daly L Wels J Theilen T Granitto S Zhang X 2013 The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis Neoplasia 15 848 IN845 23814496 PMC3689247
  7. Chen JJ Yao PL Yuan A Hong TM Shun CT Kuo ML Lee YC Yang PC 2003 Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer Clin Cancer Res 9 12576442
  8. Chen TJ Kotecha N 2014 Cytobank: providing an analytics platform for community cytometry data analysis and collaboration High-Dimensional Single Cell Analysis (Springer) 127 157 24590675
  9. Desch AN Gibbings SL Goyal R Kolde R Bednarek J Bruno T Slansky JE Jacobelli J Mason R Ito Y 2016 Flow Cytometric Analysis of Mononuclear Phagocytes in Nondiseased Human Lung and Lung-Draining Lymph Nodes Am J Respir Crit Care Med 193 614 626 26551758 PMC4824940
  10. Dieu-Nosjean MC Antoine M Danel C Heudes D Wislez M Poulot V Rabbe N Laurans L Tartour E de Chaisemartin L 2008 Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures J Clin Oncol 26 4410 4417 18802153
  11. Dutertre CA Wang LF Ginhoux F 2014 Aligning bona fide dendritic cell populations across species Cell Immunol 291 3 10 25262488
  12. Engblom C Pfirschke C Pittet MJ 2016 The role of myeloid cells in cancer therapies Nat Rev Cancer 16 447 462 27339708
  13. Fehrenbacher L Spira A Ballinger M Kowanetz M Vansteenkiste J Mazieres J Park K Smith D Artal-Cortes A Lewanski C 2016 Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial Lancet 387 1837 1846 26970723
  14. Gabrilovich DI Ostrand-Rosenberg S Bronte V 2012 Coordinated regulation of myeloid cells by tumours Nat Rev Immunol 12 253 268 22437938 PMC3587148
  15. Goc J Germain C Vo-Bourgais TK Lupo A Klein C Knockaert S de Chaisemartin L Ouakrim H Becht E Alifano M 2014 Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells Cancer Res 74 705 715 24366885
  16. Goldstraw P Chansky K Crowley J Rami-Porta R Asamura H Eberhardt WEE Nicholson AG Groome P Mitchell A Bolejack V 2016 The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer Journal of Thoracic Oncology 11 39 51 26762738
  17. Haniffa M Collin M Ginhoux F 2013 Ontogeny and functional specialization of dendritic cells in human and mouse Adv Immunol 120 1 49 24070379
  18. Hanna RN Cekic C Sag D Tacke R Thomas GD Nowyhed H Herrley E Rasquinha N McArdle S Wu R 2015 Patrolling monocytes control tumor metastasis to the lung Science 350 985 990 26494174 PMC4869713
  19. Herbst RS Soria JC Kowanetz M Fine GD Hamid O Gordon MS Sosman JA McDermott DF Powderly JD Gettinger SN 2014 Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients Nature 515 563 567 25428504 PMC4836193
  20. Jaitin DA Kenigsberg E Keren-Shaul H Elefant N Paul F Zaretsky I Mildner A Cohen N Jung S Tanay A 2014 Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types Science 343 776 779 24531970 PMC4412462
  21. Joshi NS Akama-Garren EH Lu Y Lee DY Chang GP Li A DuPage M Tammela T Kerper NR Farago AF 2015 Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses Immunity 43 579 590 26341400 PMC4826619
  22. Kirsch I Vignali M Robins H 2015 T-cell receptor profiling in cancer Mol Oncol 9 2063 2070 26404496 PMC5528728
  23. Lavin Y Merad M 2013 Macrophages: Gatekeepers of Tissue Integrity Cancer Immunology Research 1 201 209 24777851 PMC4144820
  24. Lavin Y Winter D Blecher-Gonen R David E Keren-Shaul H Merad M Jung S Amit I 2014 Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment Cell 159 1312 1326 25480296 PMC4437213
  25. Levine JH Simonds EF Bendall SC Davis KL Amir E-A Tadmor MD Litvin O Fienberg HG Jager A Zunder ER 2015 Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis Cell 162 184 197 26095251 PMC4508757
  26. Moussion C Girard JP 2011 Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules Nature 479 542 546 22080953
  27. Naidoo J Wang X Woo KM Iyriboz T Halpenny D Cunningham J Chaft JE Segal NH Callahan MK Lesokhin AM Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy Journal of Clinical Oncology 0 JCO.2016.2068.2005 PMC5559901 27646942
  28. Nishino M Giobbie-Hurder A Hatabu H Ramaiya NH Hodi F 2016 Incidence of programmed cell death 1 inhibitor–related pneumonitis in patients with advanced cancer: A systematic review and meta-analysis JAMA Oncology 2 1607 1616 27540850
  29. Paul F Arkin Ya Giladi A Jaitin DA Kenigsberg E Keren-Shaul H Winter D Lara-Astiaso D Gury M Weiner A 2015 Transcriptional heterogeneity and lineage commitment in myeloid progenitors Cell 163 1663 1677 26627738
  30. Pham CT 2006 Neutrophil serine proteases: specific regulators of inflammation Nat Rev Immunol 6 541 550 16799473
  31. Pignon JP Tribodet H Scagliotti GV Douillard JY Shepherd FA Stephens RJ Dunant A Torri V Rosell R Seymour L 2008 Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 3552 3559 18506026
  32. Pitzalis C Jones GW Bombardieri M Jones SA 2014 Ectopic lymphoid-like structures in infection, cancer and autoimmunity Nat Rev Immunol 14 447 462 24948366
  33. Qian B-Z Li J Zhang H Kitamura T Zhang J Campion LR Kaiser EA Snyder LA Pollard JW 2011 CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis Nature 475 222 225 21654748 PMC3208506
  34. Reddy RC 2008 Immunomodulatory Role of PPAR-γ in Alveolar Macrophages Journal of Investigative Medicine 56 522 527 18317435
  35. Remark R Merghoub T Grabe N Litjens G Damotte D Wolchok JD Merad M Gnjatic S 2016 In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide Science Immunology 1 aaf6925 28783673 PMC10152404
  36. Ricote M Li AC Willson TM Kelly CJ Glass CK 1998 The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 79 82 9422508
  37. Ritchie ME Phipson B Wu D Hu Y Law CW Shi W Smyth GK 2015 limma powers differential expression analyses for RNA-sequencing and microarray studies Nucleic acids research gkv007 PMC4402510 25605792
  38. Roberts EW Broz ML Binnewies M Headley MB Nelson AE Wolf DM Kaisho T Bogunovic D Bhardwaj N Krummel MF 2016 Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma Cancer Cell 30 324 336 27424807 PMC5374862
  39. Robins H Desmarais C Matthis J Livingston R Andriesen J Reijonen H Carlson C Nepom G Yee C Cerosaletti K 2012 Ultra-sensitive detection of rare T cell clones Journal of immunological methods 375 14 19 21945395 PMC3721519
  40. Robins HS Campregher PV Srivastava SK Wacher A Turtle CJ Kahsai O Riddell SR Warren EH Carlson CS 2009 Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells Blood 114 4099 4107 19706884 PMC2774550
  41. Robinson MD Oshlack A 2010 A scaling normalization method for differential expression analysis of RNA-seq data Genome Biol 11 R25 20196867 PMC2864565
  42. Salmon H Franciszkiewicz K Damotte D Dieu-Nosjean MC Validire P Trautmann A Mami-Chouaib F Donnadieu E 2012 Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors J Clin Invest 122 899 910 22293174 PMC3287213
  43. Salmon H Idoyaga J Rahman A Leboeuf M Remark R Jordan S Casanova-Acebes M Khudoynazarova M Agudo J Tung N 2016 Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition Immunity 44 924 938 27096321 PMC4980762
  44. Sánchez-Paulete AR Cueto FJ Martínez-López M Labiano S Morales-Kastresana A Rodríguez-Ruiz ME Jure-Kunkel M Azpilikueta A Aznar MA Quetglas JI 2016 Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti–PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells Cancer Discovery 6 71 79 26493961 PMC5036540
  45. Spira A Beane JE Shah V Steiling K Liu G Schembri F Gilman S Dumas YM Calner P Sebastiani P 2007 Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer Nat Med 13 361 366 17334370
  46. Suzuki K Kadota K Sima CS Nitadori J Rusch VW Travis WD Sadelain M Adusumilli PS 2013 Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor beta2 (IL-12Rbeta2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence J Clin Oncol 31 490 498 23269987 PMC3731922
  47. Turley SJ Cremasco V Astarita JL 2015 Immunological hallmarks of stromal cells in the tumour microenvironment Nat Rev Immunol 15 669 682 26471778
  48. van der Maaten L 2014 Accelerating t-SNE using tree-based algorithms Journal of machine learning research 15 3221 3245
  49. van der Maaten L Hinton G 2008 Visualizing Data using t-SNE Journal of Machine Learning Research 9 2579 2605
  50. Wendel M Galani IE Suri-Payer E Cerwenka A 2008 Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands Cancer Res 68 8437 8445 18922917
  51. Yona S Jung S 2010 Monocytes: subsets, origins, fates and functions Curr Opin Hematol 17 53 59 19770654
  52. Yoshie O Matsushima K 2015 CCR4 and its ligands: from bench to bedside Int Immunol 27 11 20 25087232
  53. Yu H Lee H Herrmann A Buettner R Jove R 2014 Revisiting STAT3 signalling in cancer: new and unexpected biological functions Nat Rev Cancer 14 736 746 25342631
  54. Yu YR Hotten DF Malakhau Y Volker E Ghio AJ Noble PW Kraft M Hollingsworth JW Gunn MD Tighe RM 2016 Flow Cytometric Analysis of Myeloid Cells in Human Blood, Bronchoalveolar Lavage, and Lung Tissues Am J Respir Cell Mol Biol 54 13 24 26267148 PMC4742930
  55. Zhu W Germain C Liu Z Sebastian Y Devi P Knockaert S Brohawn P Lehmann K Damotte D Validire P 2015 A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+ T cell receptor repertoire clonality OncoImmunology 4 e1051922 26587322 PMC4635865
  56. Zhu YM Webster SJ Flower D Woll PJ 2004 Interleukin-8/CXCL8 is a growth factor for human lung cancer cells Br J Cancer 91 1970 1976 15545974 PMC2409768

Cited by

Sorted by citations

Authors
Lavin, Y., Kobayashi, S., Leader, A., Amir, E.-A. D., Elefant, N., Bigenwald, C., Remark, R., Sweeney, R., Becker, C. D., Levine, J. H., Meinhof, K., Chow, A., Kim-Shulze, S., Wolf, A., Medaglia, C., Li, H., Rytlewski, J. A., Emerson, R. O., Solovyov, A., Greenbaum, B. D., Sanders, C., Vignali, M., Beasley, M. B., Flores, R., Gnjatic, S., Pe’er, D., Rahman, A., Amit, I., & Merad, M.
Affiliations
  • Tisch Cancer Institute (US)
  • Weizmann Institute of Science (IL)
  • Icahn School of Medicine at Mount Sinai (US)
  • Adaptive Biotechnologies (United States) (US)
Venue
Cell
Publisher
Elsevier BV
Published
2017-05
Volume
169
Issue
4
Pages
750-765.e17
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2611596972
Cited by
1,209
References
9
Citations by year
2026: 78 · 2025: 99 · 2024: 99 · 2023: 116 · 2022: 175 · 2021: 193 · 2020: 175 · 2019: 120 · 2018: 108 · 2017: 41 · 2015: 1
FWCI
53.66
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Foundation pour la Recherche Medicale (DEA20150633125)
  • NIH (R01, R01 CA173861, U19AI128949, U24 AI 118644, U19 AI 117873-01)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
early-stage lung adenocarcinoma, tumor immune microenvironment, innate immunity, T cell compartment, natural killer cells, tumor-infiltrating myeloid cells, barcoding, stage I lung cancer
MeSH terms
Adenocarcinoma of Lung, Adenocarcinoma, Dendritic Cells, Humans, Immunity, Innate, Killer Cells, Natural, Lung Neoplasms, Macrophages, T-Lymphocytes, Single-Cell Analysis, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review